Source: Pigment Cell & Melanoma Research. Conference titles: International Congress of the Society for Melanoma Research. Unidade: FCF
Subjects: CITOCINAS, ANTINEOPLÁSICOS
ABNT
SANDRI, Silvana et al. The BRAF-inhibitor contributes for the antitumor immune response by decreasing kynurenine and cytokines production. Pigment Cell & Melanoma Research. Hoboken: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 15 out. 2024. , 2013APA
Sandri, S., Migliorini, S., Campa, A., & Maria-Engler, S. S. (2013). The BRAF-inhibitor contributes for the antitumor immune response by decreasing kynurenine and cytokines production. Pigment Cell & Melanoma Research. Hoboken: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Sandri S, Migliorini S, Campa A, Maria-Engler SS. The BRAF-inhibitor contributes for the antitumor immune response by decreasing kynurenine and cytokines production. Pigment Cell & Melanoma Research. 2013 ; 26( 6): 996-997.[citado 2024 out. 15 ]Vancouver
Sandri S, Migliorini S, Campa A, Maria-Engler SS. The BRAF-inhibitor contributes for the antitumor immune response by decreasing kynurenine and cytokines production. Pigment Cell & Melanoma Research. 2013 ; 26( 6): 996-997.[citado 2024 out. 15 ]